TREATMENTS — DIGITAL THERAPEUTICS
Best CBT-I online programs in 2026
Five programs that count as actual CBT-I, four pretenders to skip, and the conditions under which DIY outperforms all nine.
CBT-I is the AASM 2021 first-line treatment for chronic insomnia. It outperforms sleep medications long-term, has no withdrawal pattern, and produces durable improvements after the treatment ends. The hard part is access: there are roughly 700 board-certified behavioral sleep medicine specialists in the United States and tens of millions of people with chronic insomnia.
Digital CBT-I exists to close that gap. The best programs deliver the same five components a clinician would (sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, relaxation training) with response rates within reach of face-to-face care. The rest are sleep-hygiene-as-app, dressed up in a CBT-I-adjacent vocabulary.
What CBT-I actually contains
CBT-I is not one technique. It's a structured protocol typically delivered over 4–8 sessions that combines five components, each with independent evidence:
Sleep restriction therapy (Spielman 1987) — compress time in bed to match average total sleep time, expand as efficiency improves. Largest single-component effect size.
Stimulus control therapy (Bootzin 1972) — six rules that rebuild the bed-equals-sleep association. Second-largest single-component effect size.
Cognitive restructuring — identify and challenge sleep-related thoughts ("if I don't sleep I can't function tomorrow", clock-checking catastrophization). The component most dependent on skilled delivery.
Sleep hygiene — the baseline practices everyone has heard. On their own, ineffective for chronic insomnia; as a component of a structured protocol, they remove confounds.
Relaxation training — progressive muscle relaxation, paced breathing, or imagery. Often the entry point because it's the most familiar; on its own, smallest effect of the five.
Why digital CBT-I exists
Three structural facts produced the digital CBT-I category. First, clinician supply: ~700 board-certified behavioral sleep medicine specialists in the US versus tens of millions of patients. Second, cost: an in-person 8-session course runs $1,500–$3,500 in most US markets, mostly uncovered by insurance. Third, geography: most clinicians cluster around academic centers; entire states have one or none.
A digital program is a deliverable form of the same active ingredients, with the cognitive-component delivery replaced by structured questionnaires, branching scenarios, and AI-driven personalization. Response rates in head-to-head trials sit roughly 10–15 percentage points below face-to-face care, with cost typically one-fifth as much.
The evidence base
Sleepio carries the bulk of the RCT evidence. Espie 2012 (Sleep journal) was the first placebo-controlled RCT with response rates comparable to clinician-delivered CBT-I. Espie 2019 (JAMA Psychiatry) replicated and extended. Pillai 2022 and several follow-ups have confirmed maintenance of gains at 6 and 12 months.
Somryst is the only FDA-cleared prescription digital therapeutic for chronic insomnia (cleared 2020). The pivotal trial (Christensen 2016, Lancet Psychiatry) showed insomnia severity index reductions comparable to face-to-face CBT-I in a 303-participant RCT.
Other programs (Stellar, Sleep Reset, Insomnia Coach by the VA) have more limited evidence, ranging from small pilot trials to no published RCT. "More limited" doesn't mean ineffective — it means the program may still work but the confidence interval is wider.
Sleepio is a 6-week structured CBT-I program built around an animated clinician persona. Covers all five components. Six published RCTs with response rates approaching face-to-face care. UK NHS-approved; in the US, sold direct-to-consumer with intermittent insurance coverage. Best fit when you want the structure and the cognitive-component delivery you can't easily reproduce alone.
Somryst — FDA-cleared, prescription only
Somryst is a US-only prescription digital therapeutic, cleared by the FDA in March 2020 under the Software as a Medical Device pathway. It's specifically indicated for chronic insomnia in adults; the prescription requirement means a clinician has reviewed your case before you start.
The clinical protocol mirrors Sleepio's: 9 weeks of structured CBT-I delivered via smartphone, with sleep restriction, stimulus control, cognitive restructuring, and relaxation. Cost runs $300–$900 depending on insurance and prescribing path.
Best fit when: you want the FDA-cleared label, you have insurance willing to cover a digital therapeutic, or you specifically need the prescription pathway (some employer health plans only reimburse if the program is prescribed). Worth less than the price differential versus Sleepio if you don't need the prescription specifically.
Stellar, Insomnia Coach, Sleep Reset — and others
Stellar Sleep is a newer entrant with a less detailed cognitive-component delivery than Sleepio; it leans heavier on sleep restriction and stimulus control. Limited published evidence so far. Roughly $250 for the program.
Insomnia Coach is a free VA-developed app, originally for veterans with insomnia, now publicly available. Covers the five components but with less personalization and no clinician interaction. The price (zero) makes it the cheapest credible option; trade-off is structure and feedback.
Sleep Reset is a coaching-plus-app model with human sleep coaches via messaging. The coaching adds an accountability lever; the underlying protocol is standard CBT-I. Cost runs $250–$500. Worth it for people who know they won't follow through on a pure-app program.
DIY versus an app — when each makes sense
DIY CBT-I using the calculator on this site, the SRT examples article, and the stimulus-control article delivers the same active ingredients as any branded program. The difference is structure, accountability, and the cognitive-component component.
DIY is the right choice when: you've read the articles, you're willing to log diligently for 7 nights of baseline plus 4–6 weeks of protocol, your case is straightforward sleep-onset or sleep-maintenance, and your cognitive component is not the dominant feature. About half of motivated readers fall in this group.
App-based is the right choice when: you've tried DIY for 2–3 weeks and stopped because the protocol was hard to track, your case includes prominent racing thoughts or rumination where the structured cognitive component matters, you need the prescription pathway (insurance reimbursement, employer health benefits), or you simply respond better to external structure than self-directed protocols. The other half.
Red flags — programs that are not CBT-I
Several apps market themselves with CBT-I language but deliver something else. The two patterns to watch for:
First, sleep-hygiene apps dressed up as CBT-I. If the program centers on "establishing a wind-down routine" and "sleep-friendly habits" with no sleep-restriction or stimulus-control component, it's sleep hygiene with branding. Sleep hygiene alone has small effect sizes for chronic insomnia; calling it CBT-I doesn't change that.
Second, meditation apps with a sleep section. Headspace, Calm, and others have meditation content for sleep that can help acute stress-related sleep difficulty. They are not CBT-I and don't claim to be. If you have chronic insomnia (3+ months, 3+ nights/week), a meditation app is not the right tier of intervention.
Third, AI "sleep coaches" with no underlying protocol. A program that doesn't tell you a specific bedtime, doesn't apply sleep restriction, and doesn't include any cognitive restructuring is not CBT-I — regardless of what the marketing copy says.
The companion piece on CBT-I versus sleeping pills covers why CBT-I is first-line and how the comparison breaks down across short-term and long-term outcomes.
The specific implementation of the sleep-restriction component is covered in sleep restriction therapy.
Seven worked weekly examples of SRT — including the cases that produce the most questions when running it inside a digital program — are in sleep restriction therapy schedule examples.
The stimulus-control component is covered in stimulus control therapy.
The cognitive component most apps ship — cognitive shuffle — is fully covered in mind racing at bedtime; useful as a no-cost pairing.
If anxiety is the dominant driver, anxiety insomnia covers the modifications that improve digital CBT-I outcomes for this subtype.
If your insomnia is under 3 months and not yet chronic, acute vs chronic insomnia covers whether a structured program is the right call yet.
When digital programs aren't enough, the next step is online sleep doctor telehealth for live clinician contact.
If you've tried trackers and the data fed the loop, orthosomnia covers the structured break protocol — and many digital CBT-I programs include continuous tracking that may amplify the same pattern.
The full set of treatment articles lives at the treatments hub.
FAQ
Does insurance cover digital CBT-I?
Patchy and rapidly changing. Somryst (FDA-cleared) has the best coverage path because it's prescription-based. Sleepio is increasingly covered by employer health benefits but rarely by standard health insurance. Check directly with your insurer; the field is moving.
Is the free VA Insomnia Coach app as good as Sleepio?
It contains the same CBT-I components and is built on the same protocols. It does not have the personalization, branching cognitive component, or accountability nudges of paid programs. For a disciplined, motivated user, the gap is small. For a less structured user, the gap is meaningful.
App alone, or app plus a therapist?
For straightforward chronic insomnia without significant comorbid anxiety or depression, app alone has equivalent response rates to app-plus-therapist in the head-to-head trials. For comorbid presentations — generalized anxiety, depression, PTSD-related insomnia — the addition of a therapist (or at minimum a CBT-trained primary care clinician) improves outcomes.
Can I use a CBT-I program while taking sleep medications?
Yes, and most clinicians prefer to start CBT-I while medications are stabilized rather than first tapering. Once CBT-I is established and producing response, a gradual medication taper is the standard sequence. Don't taper a long-term hypnotic without clinician oversight.
How long until I see results?
Most published RCTs show measurable improvement in sleep onset latency and wake-after-sleep-onset by week 3–4. Subjective sleep quality improvements lag the architectural improvements by a week or two. Response rates plateau around week 6–8; if you're not responding by week 8, the assumption shifts to differential (OSA screen, depression screen, medication review).
Sources
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine 2017.
- Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, Brown JS. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 2012.
- Espie CA, Emsley R, Kyle SD, Gordon C, Drake CL, Siriwardena AN, Cape J, Ong JC, Sheaves B, Foster R, Freeman D, Costa-Font J, Marsden A, Luik AI. Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical trial. JAMA Psychiatry 2019.
- Christensen H, Batterham PJ, Gosling JA, Ritterband LM, Griffiths KM, Thorndike FP, Glozier N, O'Dea B, Hickie IB, Mackinnon AJ. Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study). Lancet Psychiatry 2016 — pivotal trial for the SHUTi/Somryst lineage.
- Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 2006.